Telemedicine Making Drug Trials Cheaper And Quicker

The following excerpt comse from Forbes/Wolfe Emerging Technology Report’s recent full-length interview with Noah Craft, M.D., Ph.D., DTMH, the co-founder and CEO of Science 37. (Full disclosure: my venture firm Lux Capital is an equity investor.)

from Forbes – Tech http://ift.tt/1jUajUW
via IFTTT